Tuan Dong Si, MD, is a seasoned biopharma executive with over 20 years of leadership experience in drug safety and pharmacovigilance. They are currently the Senior Vice President of Drug Safety & Pharmacovigilance at Nuvalent, Inc. and previously held senior roles at Apellis Pharmaceuticals and various other prominent companies. Tuan's academic background includes medical degrees in Neurology, Molecular Biology, and Psychiatry from prestigious institutions. Their expertise spans multiple therapeutic areas, including oncology, rare diseases, and CNS disorders.
Location
Boston, United States